Tasimelteon Oral Suspension — Blue Cross Blue Shield Of Illinois
5 indications indexed for this drug.
- Any Indication When Member Resides In Ohio And Plan Is FullyView coverage criteria
- Nighttime Sleep Disturbances Associated With Smith Magenis SView coverage criteria
- Non 24 Hour Sleep Wake Disorder In Totally Blind Patients NoView coverage criteria
- Other Fda Labeled Indications For Requested Agent And RouteView coverage criteria
- Other Indications Supported In Compendia For Requested AgentView coverage criteria